Announcements Trials
Browse Landscape

Phase

Phase 1 80Phase 2 48Phase 1/2 23Phase 3 8Phase NA 5Phase EARLY_PHASE1 1Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 29INDUSTRY 3NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 5Prostatic Neoplasms 4Colonic Neoplasms 4Breast Neoplasms 4Ovarian Neoplasms 3Lung Neoplasms 3Rectal Neoplasms 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Kidney Neoplasms 2Colorectal Neoplasms 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Staphylococcal Infections 1Sarcoma 1Pituitary Neoplasms 1Pituitary ACTH Hypersecretion 1Pancreatic Neoplasms 1Neurofibromatoses 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Mesothelioma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × NIH × Neoplasm Metastasis × Clear all
NCT02069080 2018-07-12

Imaging CXCR4 Expression in Subjects With Cancer Using 64 Cu-Plerixafor

National Institutes of Health Clinical Center (CC)

Phase EARLY_PHASE1 Terminated
2 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡